GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › BAX growth analysis
Growth stock analysis · updated 2026-07-27

Baxter International Inc. (BAX) growth stock analysis

Is Baxter International Inc. a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
19
Growth score
64
RS rating
#3,579
Rank
0/6
Traits passed
19/99
Growth score · 3579th of 4,897 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about BAX

As of the 2026-07-27 close, BAX scores 19 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 3579th of 4,897 rated US stocks, the top 73% of the market.

Its strongest trait is I (institutional sponsorship) at 50, and its weakest is A (annual earnings growth) at 0. BAX clears 0 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, BAX carries a middling Relative Strength rating of 64, meaning it has outperformed about 64% of the market over the past year.

Underneath the score: quarterly earnings down 112% year over year, sales up 3%, trading 20% below its 52-week high.

BAX growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
10
A
Annual earnings growth
multi-year earnings trend
0
N
New highs & catalysts
proximity to new 52-week highs
10
S
Supply & demand
volume behind the move vs. share supply
25
L
Leader or laggard
Relative Strength within its group
50
I
Institutional sponsorship
fund accumulation and 13F ownership
50

Is BAX a growth stock?

Not right now by CANSLIM

On today’s data BAX does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than BAX

The stocks ranking above BAX today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 BAX price history & buy range

Where BAX sits in its base, its 52-week path, and the trait trend over the past year.

Open the full BAX profile →

See where BAX ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

BAX as a growth stock, frequently asked

Is BAX a good growth stock?

Not right now by CANSLIM. On today’s data BAX does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is BAX's growth score?

Baxter International Inc. (BAX) scores 19 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 3579th of 4,897 rated US stocks.

Does BAX have strong earnings growth?

BAX's most recent quarterly earnings were down about 112% year over year, with sales up 3%.

How strong is BAX's price performance?

BAX has a Relative Strength rating of 64, meaning it has outperformed roughly 64% of the US market over the trailing year.

Where can I see BAX's full analysis?

Create a free Growth Stock Analyzer account to see where BAX ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Surgical & Medical Instruments & Apparatus